Methylphenidate Teva Hart hylki með breyttan losunarhraða 10 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate teva hart hylki með breyttan losunarhraða 10 mg

teva b.v.* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 10 mg

Methylphenidate Teva Hart hylki með breyttan losunarhraða 20 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate teva hart hylki með breyttan losunarhraða 20 mg

teva b.v.* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 20 mg

Methylphenidate Teva Hart hylki með breyttan losunarhraða 30 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate teva hart hylki með breyttan losunarhraða 30 mg

teva b.v.* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 30 mg

Methylphenidate Teva Hart hylki með breyttan losunarhraða 60 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate teva hart hylki með breyttan losunarhraða 60 mg

teva b.v.* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 60 mg

Attentin Tafla 10 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

attentin tafla 10 mg

medice arzneimittel pütter gmbh & co. kg* - dexamfetaminum súlfat - tafla - 10 mg

Attentin Tafla 20 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

attentin tafla 20 mg

medice arzneimittel pütter gmbh & co. kg* - dexamfetaminum súlfat - tafla - 20 mg

Attentin Tafla 5 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

attentin tafla 5 mg

medice arzneimittel pütter gmbh & co. kg* - dexamfetaminum súlfat - tafla - 5 mg

Vydura Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

vydura

pfizer europe ma eeig  - rimegepant - mígreni kvilla - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.